Why the study?
Does propofol improve recovery times and reduce side effects compared to methohexital in healthy young women undergoing outpatient anesthesia?
Does propofol improve recovery times and reduce side effects compared to methohexital in healthy young women undergoing outpatient anesthesia?
Propofol is a useful alternative to methohexital for outpatient anesthesia, offering shorter recovery times and fewer side effects.
Favors propofol over methohexital for outpatient anesthesia in young women; confirms recovery and tolerability advantages in this RCT.
Propofol is an intravenous anesthetic currently available for clinical investigative use. The intraoperative and postoperative effects of propofol were compared to methohexital when used as an adjuvant to nitrous oxide for outpatient anesthesia. Sixty healthy young women were randomly assigned to receive either methohexital, 1.5 mg/kg intravenously (IV), or propofol, 2.5 mg/kg IV, for induction of anesthesia. Both drugs produced transient cardiovascular and respiratory depression after induction. Maintenance of anesthesia consisted of either methohexital, 6 ± 2 mg/min, or propofol, 7 ± 2 mg/min (mean ± SD) by continuous infusion in combination with nitrous oxide, 70% in oxygen. Use of a propofol infusion was associated with lower blood pressures and heart rates during maintenance. Propofol was associated with fewer side effects (e.g., hiccoughing, nausea, and vomiting) intra- and postoperatively. Recovery times for awakening, orientation, and ambulation were consistently shorter with propofol. We conclude that propofol is a useful alternative to methohexital for induction and maintenance of outpatient anesthesia.
No takes yet. Share an insight, caveat, or question.
Doze et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: